未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study Girard, N.; Guisier, F.; Swalduz, A.; Van Hulst, S.; Pichon, E.; Lavaud, P.; Greillier, L.; Tiotiu, A.; Madroszyk, A.; Bylicki, O.; Canellas, A.; Belmont, L.; Zysman, M.; Hauss, P. -a.; Godbert, B.; Audigier-Valette, C.; Lebreton, C.; Morin, F.; Westeel, V. 分享 收藏
Real-world effectiveness and safety of sotorasib in patients with KRAS G12C mutated metastatic non-small cell lung cancer (NSCLC): Results of the IFCT-2102 Lung KG12Ci study Wislez, M.; Mascaux, C.; Cadranel, J.; Thomas, Q.; Ricordel, C.; Swalduz, A.; Pichon, E.; Veillon, R.; Gounant, V.; Bussac, G. Rousseau; Flandin, A-C. Madroszyk; Daniel, C.; Ravoire, M.; Metivier, A-C.; Fournel, P.; Missy, P.; Morin, F.; Guisier, F.; Westeel, V. 分享 收藏
Osimertinib in patients with EGFR-mutated NSCLC and leptomeningeal or brain metastases: Results of the IFCT-1804 ORBITAL trial Planchard, D.; Toffart, A. C.; Flandin, A-C. Madroszyk; Wislez, M.; Martinez, S.; Monnet, I.; Hiret, S.; Gounant, V.; Metivier, A-C.; Domblides, C.; Giroux-Leprieur, E.; Huchot, E.; Tomasini, P.; Mascaux, C.; Carmier, D.; Langlais, A.; Morin, F.; Westeel, V.; Cortot, A. 分享 收藏
Impact of a minimal versus CT-scan-based follow-up on patient-reported outcomes for completely resected non-small cell lung cancer (NSCLC) in phase III IFCT-0302 trial Eberst, G.; Henriques, J.; Monchatre, M.; Giroux-Leprieur, E.; Kelkel, E.; Thaminy, A. Bizieux; Ravier, P.; Thomas, P.; Bayle, S.; Valette, C. Audigier; Berard, H.; Desliers, F.; Lagrange, A.; Bonnefoy, P.; Langlais, A.; Vernerey, D.; Anota, A.; Morin, F.; Westeel, V. 分享 收藏
Nivolumab (Nivo) plus ipilimumab (Ipi) 6-months treatment versus continuation in patients with advanced non-small cell lung cancer (aNSCLC): Results of the randomized IFCT-1701 phase III trial Zalcman, G.; Flandin, A-C. Madroszyk; Molinier, O.; Dayen, C.; Egenod, T.; Debieuvre, D.; Beaucaire-Danel, S.; Dixmier, A.; Pichon, E.; Girodet, S. Galland; Giroux-Leprieur, E.; Cloarec, N.; Cadranel, J.; Otto, J.; Romand, P.; Langlais, A.; Morin, F.; Antoine, M.; Westeel, V.; Toffart, A. C. 分享 收藏
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort Lorlatinib治疗晚期间变性淋巴瘤激酶阳性非小细胞肺癌: IFCT-1803 LORLATU队列的结果 Baldacci, Simon; Besse, Benjamin; Avrillon, Virginie; Mennecier, Bertrand; Mazieres, Julien; Dubray-Longeras, Pascale; Cortot, Alexis B.; Descourt, Renaud; Doubre, Helene; Quantin, Xavier; Duruisseaux, Michael; Monnet, Isabelle; Moro-Sibilot, Denis; Cadranel, Jacques; Clement-Duchene, Christelle; Cousin, Sophie; Ricordel, Charles; Merle, Patrick; Otto, Josiane; Schneider, Sophie; Langlais, Alexandra; Morin, Franck; Westeel, Virginie; Girard, Nicolas 分享 收藏
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial Maille, Elodie; Levallet, Jerome; Dubois, Fatemeh; Antoine, Martine; Danel, Claire; Creveuil, Christian; Mazieres, Julien; Margery, Jacques; Greillier, Laurent; Gounant, Valerie; Moro-Sibilot, Denis; Molinier, Olivier; Lena, Herve; Monnet, Isabelle; Bergot, Emmanuel; Langlais, Alexandra; Morin, Franck; Sherpereel, Arnaud; Zalcman, Gerard; Levallet, Guenaelle 分享 收藏
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer Molinier, O.; Besse, B.; Barlesi, F.; Audigier-Valette, C.; Friard, S.; Monnet, I; Jeannin, G.; Mazieres, J.; Cadranel, J.; Hureaux, J.; Hilgers, W.; Quoix, E.; Coudert, B.; Moro-Sibilot, D.; Fauchon, E.; Westeel, V; Brun, P.; Langlais, A.; Morin, F.; Souquet, P. J.; Girard, N. 分享 收藏
Pathological response is an independent factor of overall survival and disease-free survival after neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC) in the IFCT-1601 IONESCO phase II trial Wislez, M.; Mazieres, J.; Lavole, A.; Zalcman, G.; Carre, O.; Egenod, T.; Caliandro, R.; Gervais, R.; Jeannin, G.; Molinier, O.; Massiani, M-A.; Langlais, A.; Morin, F.; Barthes, F. Le Pimpec; Brouchet, L.; Assouad, J.; Milleron, B.; Westeel, V.; Antoine, M.; Damotte, D. 分享 收藏
Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC) Girard, N.; Mazieres, J.; Otto, J.; Lena, H.; Lepage, C.; Egenod, T.; Smith, D.; Madelaine, J.; Geriniere, L.; El Hajbi, F.; Ferru, A.; Clement-Duchene, C.; Madroszyk, A.; Desrame, J.; Morin, F.; Langlais, A.; Michel, P.; Louvet, C.; Westeel, V.; Walter, T. 分享 收藏
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab Herbreteau, Guillaume; Langlais, Alexandra; Greillier, Laurent; Audigier-Valette, Clarisse; Uwer, Lionel; Hureaux, Jose; Moro-Sibilot, Denis; Guisier, Florian; Carmier, Delphine; Madelaine, Jeannick; Otto, Josiane; Souquet, Pierre-Jean; Gounant, Valerie; Merle, Patrick; Molinier, Olivier; Renault, Aldo; Rabeau, Audrey; Morin, Franck; Denis, Marc G.; Pujol, Jean-Louis 分享 收藏
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial 老年晚期非小细胞肺癌患者卡铂和每周紫杉醇双重化疗后切换维持化疗与观察: IFCT-1201模型试验 Quoix, Elisabeth; Audigier-Valette, Clarisse; Lavole, Armelle; Molinier, Olivier; Westeel, Virginie; Barlesi, Fabrice; Le Treut, Jacques; Pichon, Eric; Dauba, Jerome; Otto, Josiane; Moreau, Lionel; Madelaine, Jeannick; Dumont, Patrick; Margery, Jacques; Debieuvre, Didier; Renault, Patrick Aldo; Pujol, Jean-Louis; Langlais, Alexandra; Morin, Franck; Moro-Sibilot, Denis; Souquet, Pierre-Jean 分享 收藏
Autoimmune diseases in centrally reviewed thymic epithelial tumours (TET) 中央审查的胸腺上皮肿瘤 (TET) 中的自身免疫性疾病 Montanez, J. C. Benitez; Boucher, M-E.; Dansin, E.; Kerjouan, M.; Mazieres, J.; Pichon, E.; Thillays, F.; Falcoz, P. E.; Roch, B.; Oulkhouir, Y.; Calcagno, F.; Thiberville, L.; Clement-Duchene, C.; Morin, F.; Missy, P.; Thomas, P. A.; Maury, J. -M.; Molina, T.; Girard, N.; Besse, B. 分享 收藏
Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO) Wislez, M.; Mazieres, J.; Lavole, A.; Zalcman, G.; Carre, O.; Egenod, T.; Caliandro, R.; Gervais, R.; Jeannin, G.; Molinier, O.; Massiani, M. A.; Langlais, A.; Morin, F.; Barthes, F. Le Pimpec; Brouchet, L.; Assouad, J.; Milleron, B.; Damotte, D.; Antoine, M.; Westeel, V. 分享 收藏
IFCT-1602 CHIVA2 phase II trial: Nivolumab in previously treated HIV-patients with advanced non-small cell lung cancer (NSCLC) Lavole, A.; Mazieres, J.; Schneider, S.; Brosseau, S.; Kiakouama, L. M.; Greillier, L.; Guihot, A.; Abbar, B.; Baron, M.; Makinson, A.; Langlais, A.; Morin, F.; Spano, J-P.; Cadranel, J. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
分享.png){kind=icon}
收藏
